The butyrylcholinesterase K variant is a protective factor for sporadic Alzheimer's disease in women

Acta Neurol Scand. 2000 Dec;102(6):350-3. doi: 10.1034/j.1600-0404.2000.102006350.x.

Abstract

Introduction: Recent reports indicate that the K variant of the butyrylcholinesterase (BCHE) gene may act in synergism with the epsilon4 allele of apolipoprotein E (APOE) to increase the risk of Alzheimer's disease (AD), but this is controversial.

Material and methods: We genotyped for the BCHE-K and APOE epsilon4 alleles in a sample of 249 AD patients and 250 controls derived from the same region in a Spanish population.

Results: A protective effect of the K variant of BCHE with an odds ratio of 0.41 (95% confidence interval 0.19-0.86, P=0.02) was observed among non-APOE epsilon4 carriers, but it was limited to women.

Conclusion: Our study is the first to demonstrate that lower susceptibility to AD determined by the K variant of BCHE is dependent on gender.

MeSH terms

  • Aged
  • Aged, 80 and over
  • Alzheimer Disease / genetics*
  • Alzheimer Disease / physiopathology*
  • Apolipoproteins E / genetics*
  • Butyrylcholinesterase / genetics*
  • Case-Control Studies
  • Female
  • Genetic Predisposition to Disease*
  • Humans
  • Male
  • Middle Aged
  • Risk Factors

Substances

  • Apolipoproteins E
  • Butyrylcholinesterase